Cargando…
Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action
Actinic keratosis (AK) is a common pre-neoplastic skin lesion constituted by uncontrolled proliferation of atypical keratinocytes that may evolve to squamous cell carcinoma. With global prevalence increasing, AK is expected to be the most common carcinoma of the skin. Tirbanibulin is a reversible tu...
Autores principales: | Schlesinger, Todd, Stockfleth, Eggert, Grada, Ayman, Berman, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675993/ https://www.ncbi.nlm.nih.gov/pubmed/36415541 http://dx.doi.org/10.2147/CCID.S374122 |
Ejemplares similares
-
Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in Scotland
por: Dymond, Amy, et al.
Publicado: (2023) -
1% Tirbanibulin Ointment for the Treatment of Actinic
Keratoses
por: Dao, Diem-Phuong D., et al.
Publicado: (2021) -
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
por: Skov, Torsten, et al.
Publicado: (2018) -
Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study
por: Kirchberger, Michael Constantin, et al.
Publicado: (2023) -
Evaluating the Efficacy and Safety of 4% 5-Fluorouracil Cream in Patients with Actinic Keratosis: An Expert Opinion
por: STOCKFLETH, Eggert, et al.
Publicado: (2023)